Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel

The Journal of Infectious Diseases
P YagupskyR Dagan

Abstract

The prevalence and transmission of antimicrobial drug-resistant pneumococci was studied in 48 children attending a day care facility in southern Israel. Nasopharyngeal cultures were obtained every 2 weeks for 10 months, and antibiotic susceptibility of isolates was determined by disk diffusion and E-test. Relatedness of isolates was investigated by capsular typing, ribotyping, and arbitrarily primed polymerase chain reaction. Pneumococci were recovered during 362 (63%) of 573 fortnights, and 219 (60%) of these isolates showed decreased susceptibility to at least one drug; 154 (43%) were intermediately susceptible to penicillin and 51 (14%) were multiresistant. Combining the different typing methods showed that a limited number of clones circulated in the facility. Clones exhibiting decreased antibiotic susceptibility (especially 23F, intermediately susceptible to penicillin and resistant to trimethoprim-sulfamethoxazole, and multiresistant 6B) were more frequently isolated and persisted longer than did fully susceptible clones. By multivariate analysis, carriage of organisms with decreased antibiotic susceptibility was associated with young age, female sex, winter season, and exposure to antimicrobial drugs during the previous ...Continue Reading

Citations

Feb 13, 1999·Comprehensive Therapy·R L Lark, C Chenoweth
Feb 8, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J Garau
Mar 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M JohnS O'Leary
Jan 9, 2003·Obstetrics and Gynecology·Shannon D ManningMark D Pearlman
Nov 30, 1999·International Journal of Pediatric Otorhinolaryngology·A LeibermanD M Fliss
Apr 23, 2003·Vaccine·Katherine L O'Brien, Ron Dagan
Sep 2, 1999·Infectious Disease Clinics of North America·K P Klugman, S A Madhi
Aug 5, 2000·International Journal of Antimicrobial Agents·E Leibovitz, R Dagan
Nov 25, 2000·International Journal of Antimicrobial Agents·G A SyrogiannopoulosM R Jacobs
Jan 6, 2009·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Mark S La Shell, Michael S Tankersley
Feb 1, 2005·The Lancet Infectious Diseases·William P HausdorffKeith P Klugman
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N Givon-LaviN Porat
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A J Leach
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G A SyrogiannopoulosN G Beratis
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F GhaffarG H McCracken
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D FraserR Dagan
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A BorerP Yagupsky
Oct 6, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M L JolobaM R Jacobs
Aug 31, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellPatrice Courvalin
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George A SyrogiannopoulosNicholas G Beratis
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gili Regev-YochayEthan Rubinstein
May 1, 2001·The Journal of Antimicrobial Chemotherapy·M R MillarUNKNOWN ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood
Aug 10, 1999·The Pediatric Infectious Disease Journal·F GhaffarG H McCracken
Dec 6, 2001·The Pediatric Infectious Disease Journal·P YagupskyR Dagan
Feb 15, 2001·Current Opinion in Pediatrics·M Ledwith
Jun 12, 2003·The Pediatric Infectious Disease Journal·Noga Givon-LaviRon Dagan
Jul 18, 2003·The Pediatric Infectious Disease Journal·Brigittte DunaisPierre Dellamonica
Sep 29, 2006·The Pediatric Infectious Disease Journal·Pablo Yagupsky
Dec 29, 2007·The Pediatric Infectious Disease Journal·Silvia GuevaraRon Dagan
Sep 7, 2006·Journal of Clinical Microbiology·Maren K R SogstadDominique A Caugant
Aug 30, 2001·Journal of Clinical Microbiology·D BogaertP W Hermans
Jan 5, 2002·Journal of Clinical Microbiology·D GreenbergUNKNOWN CPS/LCDC IMPACT Monitoring Network

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.